Magazine Article | January 3, 2023

Anatomy Of A Biopharma VC Deal

Source: Life Science Leader

By Matthew Pillar, Editor, Bioprocess Online

From my perch in the Business of Biotech podcast studio, I’ve interviewed quite a few biopharma leaders whose careers were inspired by very personal experiences with disease.

Ray Therapeutics CEO Paul Bresge is one such leader. Until 2010, leading a biotech wasn’t on his radar. He’d built a long and successful career as a leader in unrelated industries - industrial tools and a courier service, for example. Then, his 15-year-old daughter was diagnosed with retinitis pigmentosa (RP), a rare genetic disease that causes degradation of retinal cells over time. She was going blind. Ophthalmologists told him there was nothing that could be done to save his daughter’s vision.

VIEW THE MAGAZINE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader